PTHS vs RCL · rev $16.8M vs P/E 26, rev $9.28B
Pelthos Therapeutics Inc. (PTHS) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
PTHS currently screens at market cap $94.7M. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the PTHS and RCL stock pages for the full models.
Not investment advice.